トキシコキネティクス/トキシコプロテオーム解析によるナノマテリアルの生物学的影響評価(誌上シンポジウム)  [in Japanese] Evaluation of Biological Influence of Nano-materials using Toxicokinetic and Toxicoproteomic Approach(Symposium Review)  [in Japanese]

    • 吉川 友章 YOSHIKAWA Tomoaki
    • (独)医薬基盤研究所基盤的研究部創薬プロテオミクスプロジェクト:大阪大学大学院薬学研究科附属創薬教育センター Laboratory of Pharmaceutical Proteomics, National Institute of Biomedical Innovation:The Centar for Advanced Research and Education in Drug Discovery and Development
    • 鍋師 裕美 NABESHI Hiromi
    • (独)医薬基盤研究所基盤的研究部創薬プロテオミクスプロジェクト:大阪大学大学院薬学研究科医薬基盤科学分野 Laboratory of Pharmaceutical Proteomics, National Institute of Biomedical Innovation:The Department of Biomedical Innovation, Graduate School of Pharmaceutical Sciences
    • 吉岡 靖雄 YOSHIOKA Yasuo
    • (独)医薬基盤研究所基盤的研究部創薬プロテオミクスプロジェクト:大阪大学臨床医工学融合研究センター Laboratory of Pharmaceutical Proteomics, National Institute of Biomedical Innovation:The Center for Advanced Medical Engineering and Informatics, Osaka University

Abstract

The recent development of nanotechnology has facilitated a dramatic reduction in the size of materials. Nanomaterials are nanometer-sized materials with specific physicochemical properties that are different from those of the bulk material of the same composition. Such properties make them very attractive for cosmetic and medical applications. However, nanoparticles can act on living cells or bodies at the nano-level resulting in biologically undesirable as well as desirable effects. Thus, reduction in particle size from the micro- to nano-scale not only provides benefits to diverse scientific fields but also poses potential risks to the environment and to human health. Although significant resources are aimed at exploiting the desirable properties of nanoparticles for applications in medicine or cosmetics there are only limited attempts to evaluate potentially undesirable effects in vivo. Thus, there is a pressing need for a careful consideration of the benefits and side effects to the use of nanoparticles in medicine and cosmetics. In recent years, the majority of toxic biological response induced by nanomaterials (Nanotoxicity) has focused on cell culture systems. However, data from these studies will require verification from in vivo experiments using animals. An understanding of Toxicokinetics (the relationship between the physical properties of the nanomaterials and their in vivo behavior) would provide a basis for evaluating undesirable effects. Moreover, toxicoproteomics may identify predictive bio-markers for examining nanotoxicity. In this review article, we describe the assumptions and challenges in the field of nanotoxicity and describe advances for studying nanotoxicity of nanosilicas using toxicokinetics/toxicoproteomics both in vivo and in vitro.

Journal

Journal of the Pharmaceutical Society of Japan   [List of Volumes]

Journal of the Pharmaceutical Society of Japan 128(12), 1715-1725, 2008-12-01  [Table of Contents]

The Pharmaceutical Society of Japan

References:  28

You must have a user ID to see the references.If you already have a user ID, please click "Login" to access the info.New users can click "Sign Up" to register for an user ID.

Cited by:  1

You must have a user ID to see the cited references.If you already have a user ID, please click "Login" to access the info.New users can click "Sign Up" to register for an user ID.

Preview

Preview

Codes

  • NII Article ID (NAID) :
    110007005953
  • NII NACSIS-CAT ID (NCID) :
    AN00284903
  • Text Lang :
    JPN
  • Article Type :
    Journal Article
  • ISSN :
    00316903
  • NDL Article ID :
    9732620
  • NDL Source Classification :
    ZS51(科学技術--薬学)
  • NDL Call No. :
    Z19-411
  • Databases :
    CJP  CJPref  NDL  NII-ELS  J-STAGE